Aspirin before pancreatic surgery to improve blood-clot outcomes
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether taking low-dose aspirin around the time of pancreatic head surgery (a Whipple-type operation) can improve outcomes by affecting platelet-driven clotting. You may be eligible if you have a tumor that can be surgically removed and your doctors plan a specific type of pancreatic operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic head ductal cancer that can be fully removed by surgery, with no spread to distant organs or the lining of the belly
- Your surgery plan is a pylorus-preserving partial pancreaticoduodenectomy (Whipple-type, Traverso-Longmire), done conventionally or minimally invasively
- You are between 18 and 80 years old, and you can sign consent
- Your overall health is good enough for study participation (ECOG performance status 2 or less)
- Before surgery, you are NOT taking blood thinners or blood-platelet medicines (including aspirin/NSAIDs) on a regular basis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
This trial tests if taking propranolol (a blood pressure medication) before surgery helps treat pancreatic cancer that can be removed. It aims to see if the drug is safe and works well.
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
This trial tests if taking aspirin daily can prevent repeated attacks of acute pancreatitis. It's for people who have had at least two episodes of pancreatitis in the past year that were not caused by a medical procedure.
This study tests an experimental drug, ASP2138, given before surgery for pancreatic cancer that is still removable. After surgery, you will receive standard chemotherapy. The goal is to see if adding ASP2138 before surgery helps improve outcomes.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.